Transarterial Radioembolization for the Treatment of Advanced Hepatocellular Carcinoma Invading the Right Atrium

Hepatocellular carcinoma (HCC) has the tendency to invade the portal and/or hepatic venous system. The invasion of the right atrium is uncommonly observed and constitutes a treatment challenge. We report the case of a patient with HCC invading the right atrium treated with (90)Yttrium-transarterial...

Descripción completa

Detalles Bibliográficos
Autores principales: Girardet, Raphaël, Boughdad, Sarah, Digklia, Antonia, Beigelman, Catherine, Meyer, Marie, Schaefer, Niklaus, Vermersch, Mathilde, Hocquelet, Arnaud, Tsoumakidou, Georgia, Denys, Alban, Duran, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591430/
https://www.ncbi.nlm.nih.gov/pubmed/32761249
http://dx.doi.org/10.1007/s00270-020-02605-3
Descripción
Sumario:Hepatocellular carcinoma (HCC) has the tendency to invade the portal and/or hepatic venous system. The invasion of the right atrium is uncommonly observed and constitutes a treatment challenge. We report the case of a patient with HCC invading the right atrium treated with (90)Yttrium-transarterial radioembolization ((90)Y-TARE). Following the treatment, organizing pneumonia secondary to nivolumab occurred, raising the question of an interaction between (90)Y-TARE and nivolumab. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00270-020-02605-3) contains supplementary material, which is available to authorized users.

Ejemplares similares